Moderna shows early evidence of mRNA-encoded antibody production at R&D day

Moderna unveiled the first clinical evidence of mRNA-encoded mAb production during its R&D day, which featured Phase I data for its chikungunya therapy and CMV vaccine.

No approved vaccines or therapies exist for chikungunya, a tropical mosquito-borne viral infection. And in utero CMV transmission is the most common infectious cause of birth defects globally, but there is no approved vaccine for the virus...